Introduction: Chondrocyte differentiation can be mimicked in vitro by insulin treatment of the mouse chondroprogenitor cell line ATDC5. Utilizing this property of ATDC5 cells, we carried out a large scale screening of random retroviral insertions to identify novel regulators of chondrogenesis. In this study we report the characterization of two ATDC5 clones (H8-5 and H8-6) that were unable to undergo chondrogenic differentiation after insertional mutagenesis. Sequencing of retroviral integration sites in these two clones revealed that the retroviral DNA was inserted into the promoter region of Rab23 (Ras-related in brain 23), a gene encoding a member of the Rab family of small GTPases. Interestingly, Rab23 mutations have been identified both in mice and humans, and the mutant phenotypes include defects in bone development and limb patterning. Our study provides evidence for the first time that Rab23 mutations may exert their effects on the skeletal system through down-regulation of the essential transcription factor Sox9.
Fig. 1. Effects of Rab23 knockdown on differentiation
Discussion: Mutations in Rab23 were originally found to be associated with the mouse open brain phenotype. These mutations are single-nucleotide substitutions in both mutant alleles that introduce early stop codons into the open reading frame of Rab23. In addition to neural tube defects, mouse Rab23 mutations are also associated with malformations in axial skeleton and limbs. In humans, homozygous nonsense mutations in Rab23 were recently linked to Carpenter Syndrome, a genetic disorder characterized by premature closure of cranial sutures between certain bones of the skull. Individuals with Carpenter syndrome may also have unusually short fingers and toes, polydactyly or physical abnormalities such as short stature.
Our study shows that normal differentiation of ATDC5 chondroprogenitor cells requires a specific level of Rab23 protein. Too much or too little Rab23 protein leads to down-regulation of Sox9 expression and subsequent failure of chondrogenic differentiation. Our results also suggest a potential mechanism to explain the skeletal defects associated with mutations of Rab23. Specifically, Rab23 mutations might exert their effects by down-regulating Sox9 protein leading to defective/incomplete cartilaginous anlagen.
In patients with Carpenter syndrome, it is possible that Rab23 mutations result in decreased expression of Sox9 in osteochondral progenitor cells that eventually differentiate into flat bones of the skull. Formation of flat bones of the skull does not require a cartilage precursor but instead is mediated through intramembranous ossification. In this process, osteochondral progenitor cells directly differentiate into bone-forming osteoblasts. It has already been known that downregulation of Sox9 coincides with terminal differentiation of osteoblasts in developing craniofacial bones. Our study suggests that Rab23 mutations leads to decreased levels of Sox9 protein in these osteochondral progenitor cells This in turn leads to accelerated osteoblast differentiation resulting in premature closure of the cranial sutures.
